Admin
09 Jun 2026 23:12
admin
#general
Pharmaceutical Industry Glossary of Terms and Acronyms
This glossary provides definitions for commonly used terms and acronyms in the pharmaceutical industry. It serves as a reference for professionals, students, and anyone interested in understanding the specialized vocabulary used in drug development, manufacturing, regulatory affairs, and clinical research.
A
Adverse Drug Reaction (ADR)
A harmful or undesirable reaction to a medicinal product that occurs at doses normally used for treatment.
Active Pharmaceutical Ingredient (API)
The substance in a drug that is biologically active and produces the intended therapeutic effect.
Adjuvant
A substance that enhances the immune response to an antigen, often used in vaccines to increase their effectiveness.
Androgen
A type of hormone that promotes the development and maintenance of male sex characteristics, including testosterone.
Antibiotic Resistance
The ability of bacteria to withstand the effects of an antibiotic, making infections more difficult to treat.
B
Bioavailability
The proportion of a drug that enters the circulation when introduced into the body and is able to have an active effect.
Biologics
Products derived from living organisms or their components, including vaccines, blood and blood components, gene therapies, tissues, and proteins.
Biosimilar
A biological product that is highly similar to an already approved biological product, with no clinically meaningful differences in terms of safety or effectiveness.
Biotechnology
The use of biological processes, organisms, or systems to manufacture products intended to improve human health.
C
Clinical Trials
Research studies conducted in humans to evaluate the safety and effectiveness of new drugs, medical devices, or treatment protocols.
Combination Product
A therapeutic product that combines a drug, device, and/or biological product.
Controlled Substance
A drug or chemical whose manufacture, possession, or use is regulated by the government due to potential for abuse or addiction.
Cold Chain
A temperature-controlled supply chain that maintains optimal conditions for products that require specific temperature ranges, such as certain vaccines and biologics.
D
Drug Development
The process of bringing a new pharmaceutical drug to market once a lead compound has been identified through drug discovery.
Double-Blind Study
A study in which both the investigators and participants are unaware of which treatment (experimental or control) is being administered to eliminate bias.
Dosage Form
The physical form of a medication, such as tablet, capsule, injection, cream, or inhaler.
Dossier
A compilation of documents containing data and information about a drug product, submitted to regulatory authorities for approval.
E
Efficacy
The ability of a drug to produce a desired therapeutic effect under ideal conditions, as measured in clinical trials.
Electronic Common Technical Document (eCTD)
An electronic format for submitting regulatory applications to drug authorities, standardizing the structure and content of submissions.
Excipient
An inactive substance used as a carrier for the active ingredients of a medication, helping to formulate, preserve, or deliver the drug.
Expiration Date
The date after which a pharmaceutical product should not be used due to diminished potency or safety concerns.
F
Formulation
The process of combining various chemical substances to produce a medicinal product with specific characteristics and therapeutic properties.
Food and Drug Administration (FDA)
The U.S. federal agency responsible for protecting public health by ensuring the safety, efficacy, and security of drugs, biological products, and medical devices.
First-in-Class Drug
A drug that uses a new and unique mechanism of action for treating a medical condition, representing a significant innovation in therapy.
Good Manufacturing Practice (GMP)
A system for ensuring that products are consistently produced and controlled according to quality standards.
G
Generic Drug
A medication created to be the same as an already marketed brand-name drug in dosage form, safety, strength, route of administration, quality, and intended use.
Genetically Modified Organism (GMO)
An organism whose genetic material has been altered using genetic engineering techniques, sometimes used in the production of pharmaceuticals.
Groundbreaking Therapy
A designation for drugs that show substantial improvement over available therapy for a serious condition based on preliminary clinical evidence.
H
Half-Life
The time it takes for the concentration of a drug in the body to decrease by half.
Highly Potent Active Pharmaceutical Ingredients (HPAPI)
Active pharmaceutical ingredients with significant pharmacological activity at low doses, requiring special handling and containment measures.
Hydrophilic
Having a tendency to mix with, dissolve in, or be wetted by water, an important property in drug formulation.
Hydrophobic
Having a tendency to repel or not absorb water, affecting how a drug is absorbed and distributed in the body.
I
Investigational New Drug (IND) Application
A request to the FDA for authorization to administer an investigational drug to humans, typically before clinical trials.
International Nonproprietary Name (INN)
The official generic name given to a pharmaceutical substance by the World Health Organization.
Informed Consent
The process of obtaining voluntary agreement to participate in clinical research after understanding the nature, risks, and benefits of the study.
Immunogenicity
The ability of a particular substance, such as a vaccine or therapeutic protein, to provoke an immune response.
J
Joint Commission
An independent, not-for-profit organization that accredits and certifies healthcare organizations and programs in the United States.
Just-in-Time (JIT) Manufacturing
A production strategy that aims to reduce in-process inventory and associated carrying costs by receiving goods only as they are needed.
K
Key Opinion Leader (KOL)
A respected expert in the medical or pharmaceutical field whose opinions are valued by peers and influence clinical practice.
L
Labeling
All written, printed, or graphic matter accompanying a pharmaceutical product, including package inserts, containers, and labels.
Lyophilization
A freeze-drying process used to remove water from heat-sensitive materials such as pharmaceuticals to preserve them and extend shelf life.
Life Cycle Management
The strategic planning and implementation of activities to maximize the potential of a pharmaceutical product throughout its commercial life.
Lot
A specific quantity of a drug substance or product produced under uniform conditions and identified by a distinctive code.
M
Manufacturing and Control (CMC)
The section of a regulatory application that contains information about the chemistry, manufacturing, and controls of a drug substance and product.
Medical Device
An instrument, apparatus, implement, machine, contrivance, implant, or similar article intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease.
Monoclonal Antibody
Laboratory-produced molecules engineered to serve as substitute antibodies that can restore, enhance, or mimic the immune system's attack on cells.
Marketing Authorization Application (MAA)
The formal submission seeking approval to market a pharmaceutical product in a specific jurisdiction.
Mechanism of Action (MOA)
The biochemical interaction through which a drug substance produces its pharmacological effect.
N
New Drug Application (NDA)
The formal submission to the FDA requesting approval to market a new drug in the United States.
Nutraceutical
A food or fortified food product that not only supplements the diet but also assists in treating or preventing disease.
Non-steroidal Anti-inflammatory Drug (NSAID)
A class of drugs that provides analgesic and antipyretic effects and, in higher doses, anti-inflammatory effects.
O
Orphan Drug
A pharmaceutical product developed specifically to treat a rare medical condition, often with incentives like market exclusivity.
Over-the-Counter (OTC)
Medications that can be purchased directly by consumers without a prescription from a healthcare professional.
Off-Label Use
The use of a pharmaceutical drug for an unapproved indication or in an unapproved age group, dosage, or route of administration.
P
Pharmacodynamics
The study of the biochemical and physiological effects of drugs on the body or on microorganisms within or on the body.
Pharmacokinetics
The study of how the body affects a drug after administration through absorption, distribution, metabolism, and excretion.
Pharmacogenomics
The study of how genes affect a person's response to drugs, with the goal of developing effective, safe medications tailored to genetic makeup.
Pharmacovigilance
The science and activities relating to the detection, assessment, understanding, and prevention of adverse effects or drug-related problems.
Placebo
An inactive substance or procedure designed to resemble the active treatment, used in clinical trials for comparison.
Phase I, II, III, and IV Trials
Sequential stages of clinical testing: Phase I assesses safety in healthy volunteers; Phase II evaluates effectiveness in patients; Phase III confirms efficacy with larger groups; Phase IV monitors post-marketing safety and effectiveness.
Q
Quality Assurance (QA)
The planned and systematic activities implemented within the quality system to provide confidence that the product will fulfill quality requirements.
Quality Control (QC)
The operational techniques and activities used to fulfill requirements for quality, including testing and inspection to detect defects.
R
Regulatory Affairs
The profession that ensures pharmaceutical companies comply with all regulations and laws pertaining to their products.
Randomized Controlled Trial (RCT)
A study design that randomly assigns participants to either a control or experimental group, reducing bias in the assessment of outcomes.
Route of Administration
The path by which a drug is taken into the body, such as oral, intravenous, intramuscular, topical, or inhalation.
S
Standard Operating Procedure (SOP)
Detailed written instructions to achieve uniformity of performance of a specific function in pharmaceutical operations.
Stability Testing
Studies conducted to determine how the quality of a drug substance or product varies with time under the influence of environmental factors.
Sublingual
A route of administration where medication is placed under the tongue for rapid absorption into the bloodstream.
Supplemental New Drug Application (sNDA)
A request to the FDA to approve changes to a product that already has an approved NDA, such as new indications, dosage forms, or manufacturing changes.
T
Therapeutic Index
The ratio between the toxic dose and the therapeutic dose of a drug, used as a measure of the relative safety of the drug.
Translational Medicine
The process of turning scientific discoveries from the laboratory into practical medical treatments and therapies.
Topical
Medications applied to body surfaces such as the skin or mucous membranes for local effects or systemic absorption.
U
Unmet Medical Need
A condition or disease for which there is no satisfactory treatment or existing treatments are inadequate, often a priority for pharmaceutical research.
United States Pharmacopeia (USP)
The official public standards-setting authority for all prescription and over-the-counter medicines manufactured and sold in the United States.
V
Validation
The documented act of demonstrating that a procedure, process, equipment, method, or activity performs as intended and leads to the expected results.
Vaccine
A biological preparation that provides active acquired immunity to a particular infectious disease, typically containing an agent that resembles a disease-causing microorganism.
W
World Health Organization (WHO)
A specialized agency of the United Nations responsible for international public health, including coordinating responses to health emergencies and promoting well-being.
Z
Z-Drug
Non-benzodiazepine hypnotic drugs used for the treatment of insomnia, whose names typically begin with the letter Z (e.g., zolpidem, zopiclone).
Reference Files For Pharmaceutical Industry Glossary Of Terms And Acronyms
Screenshoot
File Name
pub_life_sciences_glossary_0519.pdf
File Size
0.39 MB
File Type
PDF
File Site
Description
This file is just a reference file for Pharmaceutical Industry Glossary Of Terms And Acronyms. Does not guarantee that the specific things you want are included in it.
Direct download (wait 10 seconds)
Pharmaceutical Industry Glossary Of Terms And Acronyms and Reference File Download Link
Admin
2026-06-09 23:12:15
Glossary Of Commonly Used Acronyms, Abbreviations And Maori Translation and Reference File...
Admin
2026-06-10 00:10:18
Common Medical Terms, Abbreviations, And Acronyms Approved For Arizona WIC Use and Referen...
Admin
2026-06-10 01:40:17
Juvenile Court Terms Glossary And Acronym Guide and Reference File Download Link
Admin
2026-06-08 17:20:33
Cookie Consent
We use cookies to enhance your browsing experience and analyze site traffic. By clicking 'Accept all cookies', you agree to the use of these cookies. You can manage your preferences or learn more in our [Privacy Policy/Cookie Policy.